nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydralazine—CYP3A4—Rivastigmine—Alzheimer's disease	0.181	0.432	CbGbCtD
Hydralazine—CYP3A4—Donepezil—Alzheimer's disease	0.145	0.345	CbGbCtD
Hydralazine—CYP3A4—Galantamine—Alzheimer's disease	0.0932	0.223	CbGbCtD
Hydralazine—AOC3—blood vessel—Alzheimer's disease	0.019	0.147	CbGeAlD
Hydralazine—RYR2—Arrhythmogenic Right Ventricular Cardiomyopathy—CTNNA3—Alzheimer's disease	0.0175	0.161	CbGpPWpGaD
Hydralazine—RYR2—forebrain—Alzheimer's disease	0.0167	0.128	CbGeAlD
Hydralazine—RYR2—telencephalon—Alzheimer's disease	0.0153	0.118	CbGeAlD
Hydralazine—RYR2—nervous system—Alzheimer's disease	0.00905	0.0697	CbGeAlD
Hydralazine—RYR2—central nervous system—Alzheimer's disease	0.00872	0.0671	CbGeAlD
Hydralazine—RYR2—cerebellum—Alzheimer's disease	0.00852	0.0656	CbGeAlD
Hydralazine—P4HA1—telencephalon—Alzheimer's disease	0.00738	0.0568	CbGeAlD
Hydralazine—RYR2—brain—Alzheimer's disease	0.00692	0.0533	CbGeAlD
Hydralazine—AOC3—nervous system—Alzheimer's disease	0.00545	0.042	CbGeAlD
Hydralazine—AOC3—central nervous system—Alzheimer's disease	0.00525	0.0404	CbGeAlD
Hydralazine—AOC3—cerebellum—Alzheimer's disease	0.00513	0.0395	CbGeAlD
Hydralazine—P4HA1—nervous system—Alzheimer's disease	0.00436	0.0336	CbGeAlD
Hydralazine—Numbness—Donepezil—Alzheimer's disease	0.00431	0.0126	CcSEcCtD
Hydralazine—RYR2—SIDS Susceptibility Pathways—MAP2—Alzheimer's disease	0.0042	0.0386	CbGpPWpGaD
Hydralazine—P4HA1—central nervous system—Alzheimer's disease	0.0042	0.0323	CbGeAlD
Hydralazine—AOC3—brain—Alzheimer's disease	0.00417	0.0321	CbGeAlD
Hydralazine—Sensory loss—Donepezil—Alzheimer's disease	0.00412	0.012	CcSEcCtD
Hydralazine—P4HA1—cerebellum—Alzheimer's disease	0.0041	0.0316	CbGeAlD
Hydralazine—Numbness—Memantine—Alzheimer's disease	0.00391	0.0114	CcSEcCtD
Hydralazine—Leukocytosis—Donepezil—Alzheimer's disease	0.0038	0.0111	CcSEcCtD
Hydralazine—Sensory loss—Memantine—Alzheimer's disease	0.00374	0.0109	CcSEcCtD
Hydralazine—Vascular purpura—Galantamine—Alzheimer's disease	0.00374	0.0109	CcSEcCtD
Hydralazine—RYR2—Calcium Regulation in the Cardiac Cell—YWHAQ—Alzheimer's disease	0.00359	0.033	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—TP73—Alzheimer's disease	0.00357	0.0329	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—CHRNA7—Alzheimer's disease	0.00357	0.0329	CbGpPWpGaD
Hydralazine—RYR2—Myometrial Relaxation and Contraction Pathways—YWHAQ—Alzheimer's disease	0.00348	0.032	CbGpPWpGaD
Hydralazine—Purpura—Galantamine—Alzheimer's disease	0.00347	0.0101	CcSEcCtD
Hydralazine—RYR2—SIDS Susceptibility Pathways—YWHAQ—Alzheimer's disease	0.00346	0.0318	CbGpPWpGaD
Hydralazine—Leukocytosis—Memantine—Alzheimer's disease	0.00345	0.0101	CcSEcCtD
Hydralazine—Cardiac failure—Galantamine—Alzheimer's disease	0.00343	0.01	CcSEcCtD
Hydralazine—Leukocytosis—Rivastigmine—Alzheimer's disease	0.00337	0.00985	CcSEcCtD
Hydralazine—P4HA1—brain—Alzheimer's disease	0.00333	0.0256	CbGeAlD
Hydralazine—Vasculitis—Rivastigmine—Alzheimer's disease	0.00325	0.00948	CcSEcCtD
Hydralazine—Urinary retention—Galantamine—Alzheimer's disease	0.00318	0.00928	CcSEcCtD
Hydralazine—RYR2—SIDS Susceptibility Pathways—CHAT—Alzheimer's disease	0.00304	0.0279	CbGpPWpGaD
Hydralazine—Haemolytic anaemia—Donepezil—Alzheimer's disease	0.00287	0.00838	CcSEcCtD
Hydralazine—Cardiac failure congestive—Donepezil—Alzheimer's disease	0.00286	0.00834	CcSEcCtD
Hydralazine—RYR2—SIDS Susceptibility Pathways—HSPD1—Alzheimer's disease	0.00286	0.0263	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—GAPDH—Alzheimer's disease	0.0028	0.0258	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—ABCA7—Alzheimer's disease	0.00277	0.0255	CbGpPWpGaD
Hydralazine—Lymphadenopathy—Rivastigmine—Alzheimer's disease	0.0027	0.00787	CcSEcCtD
Hydralazine—Hepatic function abnormal—Memantine—Alzheimer's disease	0.00269	0.00786	CcSEcCtD
Hydralazine—Cardiac failure—Donepezil—Alzheimer's disease	0.00266	0.00775	CcSEcCtD
Hydralazine—Vascular purpura—Memantine—Alzheimer's disease	0.00263	0.00768	CcSEcCtD
Hydralazine—Disorientation—Memantine—Alzheimer's disease	0.00263	0.00768	CcSEcCtD
Hydralazine—Weight decreased—Galantamine—Alzheimer's disease	0.00261	0.00763	CcSEcCtD
Hydralazine—Cardiac failure congestive—Memantine—Alzheimer's disease	0.00259	0.00757	CcSEcCtD
Hydralazine—Vascular purpura—Rivastigmine—Alzheimer's disease	0.00257	0.00751	CcSEcCtD
Hydralazine—Depression—Galantamine—Alzheimer's disease	0.00257	0.0075	CcSEcCtD
Hydralazine—RYR2—SIDS Susceptibility Pathways—CHRNB2—Alzheimer's disease	0.00256	0.0236	CbGpPWpGaD
Hydralazine—Renal failure acute—Memantine—Alzheimer's disease	0.00255	0.00744	CcSEcCtD
Hydralazine—Psychotic disorder—Donepezil—Alzheimer's disease	0.00253	0.00739	CcSEcCtD
Hydralazine—Neuropathy peripheral—Galantamine—Alzheimer's disease	0.00253	0.00737	CcSEcCtD
Hydralazine—Renal failure acute—Rivastigmine—Alzheimer's disease	0.00249	0.00728	CcSEcCtD
Hydralazine—RYR2—Transmembrane transport of small molecules—SLC24A4—Alzheimer's disease	0.00247	0.0227	CbGpPWpGaD
Hydralazine—Urinary retention—Donepezil—Alzheimer's disease	0.00246	0.00719	CcSEcCtD
Hydralazine—Haematuria—Galantamine—Alzheimer's disease	0.00246	0.00717	CcSEcCtD
Hydralazine—Purpura—Memantine—Alzheimer's disease	0.00244	0.00713	CcSEcCtD
Hydralazine—Cardiac failure—Memantine—Alzheimer's disease	0.00241	0.00704	CcSEcCtD
Hydralazine—Purpura—Rivastigmine—Alzheimer's disease	0.00239	0.00697	CcSEcCtD
Hydralazine—Cardiac failure—Rivastigmine—Alzheimer's disease	0.00236	0.00688	CcSEcCtD
Hydralazine—RYR2—Myometrial Relaxation and Contraction Pathways—CRH—Alzheimer's disease	0.00234	0.0215	CbGpPWpGaD
Hydralazine—Cramp muscle—Donepezil—Alzheimer's disease	0.00233	0.00681	CcSEcCtD
Hydralazine—RYR2—SIDS Susceptibility Pathways—CHRNA4—Alzheimer's disease	0.00233	0.0214	CbGpPWpGaD
Hydralazine—Hepatitis—Galantamine—Alzheimer's disease	0.00231	0.00675	CcSEcCtD
Hydralazine—RYR2—SIDS Susceptibility Pathways—TF—Alzheimer's disease	0.0023	0.0212	CbGpPWpGaD
Hydralazine—Hallucination—Galantamine—Alzheimer's disease	0.0023	0.00672	CcSEcCtD
Hydralazine—Psychotic disorder—Memantine—Alzheimer's disease	0.0023	0.00671	CcSEcCtD
Hydralazine—Psychotic disorder—Rivastigmine—Alzheimer's disease	0.00225	0.00656	CcSEcCtD
Hydralazine—Urinary retention—Memantine—Alzheimer's disease	0.00224	0.00653	CcSEcCtD
Hydralazine—Eosinophilia—Donepezil—Alzheimer's disease	0.00222	0.00647	CcSEcCtD
Hydralazine—Urinary retention—Rivastigmine—Alzheimer's disease	0.00219	0.00639	CcSEcCtD
Hydralazine—Angina pectoris—Donepezil—Alzheimer's disease	0.00218	0.00637	CcSEcCtD
Hydralazine—RYR2—SIDS Susceptibility Pathways—SLC6A4—Alzheimer's disease	0.00216	0.0199	CbGpPWpGaD
Hydralazine—Flushing—Galantamine—Alzheimer's disease	0.00215	0.00627	CcSEcCtD
Hydralazine—RYR2—SIDS Susceptibility Pathways—SST—Alzheimer's disease	0.00211	0.0194	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—NTRK2—Alzheimer's disease	0.00211	0.0194	CbGpPWpGaD
Hydralazine—Dysuria—Donepezil—Alzheimer's disease	0.00209	0.00611	CcSEcCtD
Hydralazine—Cramp muscle—Rivastigmine—Alzheimer's disease	0.00207	0.00605	CcSEcCtD
Hydralazine—Weight decreased—Donepezil—Alzheimer's disease	0.00203	0.00591	CcSEcCtD
Hydralazine—Depression—Donepezil—Alzheimer's disease	0.00199	0.00581	CcSEcCtD
Hydralazine—Angina pectoris—Memantine—Alzheimer's disease	0.00198	0.00578	CcSEcCtD
Hydralazine—Jaundice—Donepezil—Alzheimer's disease	0.00195	0.00568	CcSEcCtD
Hydralazine—Conjunctivitis—Donepezil—Alzheimer's disease	0.00194	0.00567	CcSEcCtD
Hydralazine—Angina pectoris—Rivastigmine—Alzheimer's disease	0.00194	0.00566	CcSEcCtD
Hydralazine—Muscle spasms—Galantamine—Alzheimer's disease	0.00194	0.00565	CcSEcCtD
Hydralazine—Pancytopenia—Memantine—Alzheimer's disease	0.00193	0.00564	CcSEcCtD
Hydralazine—Haematuria—Donepezil—Alzheimer's disease	0.0019	0.00556	CcSEcCtD
Hydralazine—Neutropenia—Memantine—Alzheimer's disease	0.0019	0.00555	CcSEcCtD
Hydralazine—Dysuria—Memantine—Alzheimer's disease	0.0019	0.00555	CcSEcCtD
Hydralazine—Tremor—Galantamine—Alzheimer's disease	0.00189	0.00551	CcSEcCtD
Hydralazine—Ill-defined disorder—Galantamine—Alzheimer's disease	0.00187	0.00545	CcSEcCtD
Hydralazine—Anaemia—Galantamine—Alzheimer's disease	0.00186	0.00543	CcSEcCtD
Hydralazine—Dysuria—Rivastigmine—Alzheimer's disease	0.00186	0.00543	CcSEcCtD
Hydralazine—Agitation—Galantamine—Alzheimer's disease	0.00185	0.0054	CcSEcCtD
Hydralazine—Weight decreased—Memantine—Alzheimer's disease	0.00184	0.00537	CcSEcCtD
Hydralazine—Malaise—Galantamine—Alzheimer's disease	0.00182	0.0053	CcSEcCtD
Hydralazine—Depression—Memantine—Alzheimer's disease	0.00181	0.00528	CcSEcCtD
Hydralazine—Weight decreased—Rivastigmine—Alzheimer's disease	0.0018	0.00525	CcSEcCtD
Hydralazine—Hepatitis—Donepezil—Alzheimer's disease	0.00179	0.00523	CcSEcCtD
Hydralazine—Hallucination—Donepezil—Alzheimer's disease	0.00178	0.00521	CcSEcCtD
Hydralazine—Hypoaesthesia—Donepezil—Alzheimer's disease	0.00178	0.00521	CcSEcCtD
Hydralazine—Palpitations—Galantamine—Alzheimer's disease	0.00178	0.00519	CcSEcCtD
Hydralazine—Neuropathy peripheral—Memantine—Alzheimer's disease	0.00178	0.00519	CcSEcCtD
Hydralazine—Depression—Rivastigmine—Alzheimer's disease	0.00177	0.00516	CcSEcCtD
Hydralazine—Conjunctivitis—Memantine—Alzheimer's disease	0.00176	0.00514	CcSEcCtD
Hydralazine—Neuropathy peripheral—Rivastigmine—Alzheimer's disease	0.00174	0.00507	CcSEcCtD
Hydralazine—Haematuria—Memantine—Alzheimer's disease	0.00173	0.00505	CcSEcCtD
Hydralazine—Conjunctivitis—Rivastigmine—Alzheimer's disease	0.00172	0.00503	CcSEcCtD
Hydralazine—Arthralgia—Galantamine—Alzheimer's disease	0.00171	0.005	CcSEcCtD
Hydralazine—Myalgia—Galantamine—Alzheimer's disease	0.00171	0.005	CcSEcCtD
Hydralazine—RYR2—Transmembrane transport of small molecules—SLC30A6—Alzheimer's disease	0.00171	0.0158	CbGpPWpGaD
Hydralazine—Anxiety—Galantamine—Alzheimer's disease	0.00171	0.00499	CcSEcCtD
Hydralazine—Discomfort—Galantamine—Alzheimer's disease	0.00169	0.00494	CcSEcCtD
Hydralazine—Agranulocytosis—Memantine—Alzheimer's disease	0.00169	0.00494	CcSEcCtD
Hydralazine—Haematuria—Rivastigmine—Alzheimer's disease	0.00169	0.00494	CcSEcCtD
Hydralazine—Hepatitis—Memantine—Alzheimer's disease	0.00163	0.00475	CcSEcCtD
Hydralazine—Hypoaesthesia—Memantine—Alzheimer's disease	0.00162	0.00473	CcSEcCtD
Hydralazine—Hallucination—Memantine—Alzheimer's disease	0.00162	0.00473	CcSEcCtD
Hydralazine—RYR2—SIDS Susceptibility Pathways—PPARGC1A—Alzheimer's disease	0.00162	0.0149	CbGpPWpGaD
Hydralazine—Thrombocytopenia—Galantamine—Alzheimer's disease	0.00161	0.0047	CcSEcCtD
Hydralazine—Chills—Donepezil—Alzheimer's disease	0.00161	0.00469	CcSEcCtD
Hydralazine—Tachycardia—Galantamine—Alzheimer's disease	0.0016	0.00468	CcSEcCtD
Hydralazine—Hepatitis—Rivastigmine—Alzheimer's disease	0.00159	0.00465	CcSEcCtD
Hydralazine—Hallucination—Rivastigmine—Alzheimer's disease	0.00158	0.00462	CcSEcCtD
Hydralazine—Hypoaesthesia—Rivastigmine—Alzheimer's disease	0.00158	0.00462	CcSEcCtD
Hydralazine—RYR2—SIDS Susceptibility Pathways—BDNF—Alzheimer's disease	0.00157	0.0145	CbGpPWpGaD
Hydralazine—Anorexia—Galantamine—Alzheimer's disease	0.00157	0.00457	CcSEcCtD
Hydralazine—Hypotension—Galantamine—Alzheimer's disease	0.00154	0.00448	CcSEcCtD
Hydralazine—Flushing—Memantine—Alzheimer's disease	0.00151	0.00441	CcSEcCtD
Hydralazine—RYR2—SIDS Susceptibility Pathways—IL1A—Alzheimer's disease	0.00151	0.0139	CbGpPWpGaD
Hydralazine—Muscle spasms—Donepezil—Alzheimer's disease	0.0015	0.00438	CcSEcCtD
Hydralazine—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.0015	0.00437	CcSEcCtD
Hydralazine—RYR2—Calcium Regulation in the Cardiac Cell—PRKCG—Alzheimer's disease	0.00149	0.0137	CbGpPWpGaD
Hydralazine—Flushing—Rivastigmine—Alzheimer's disease	0.00148	0.00431	CcSEcCtD
Hydralazine—Paraesthesia—Galantamine—Alzheimer's disease	0.00148	0.00431	CcSEcCtD
Hydralazine—Tremor—Donepezil—Alzheimer's disease	0.00146	0.00427	CcSEcCtD
Hydralazine—Chills—Memantine—Alzheimer's disease	0.00146	0.00426	CcSEcCtD
Hydralazine—RYR2—SIDS Susceptibility Pathways—MEF2C—Alzheimer's disease	0.00146	0.0134	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—APOD—Alzheimer's disease	0.00146	0.0134	CbGpPWpGaD
Hydralazine—Ill-defined disorder—Donepezil—Alzheimer's disease	0.00145	0.00423	CcSEcCtD
Hydralazine—Dyspepsia—Galantamine—Alzheimer's disease	0.00145	0.00422	CcSEcCtD
Hydralazine—Anaemia—Donepezil—Alzheimer's disease	0.00144	0.00421	CcSEcCtD
Hydralazine—RYR2—Myometrial Relaxation and Contraction Pathways—PRKCG—Alzheimer's disease	0.00144	0.0132	CbGpPWpGaD
Hydralazine—Agitation—Donepezil—Alzheimer's disease	0.00143	0.00419	CcSEcCtD
Hydralazine—Chills—Rivastigmine—Alzheimer's disease	0.00143	0.00417	CcSEcCtD
Hydralazine—Decreased appetite—Galantamine—Alzheimer's disease	0.00143	0.00417	CcSEcCtD
Hydralazine—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.00142	0.00414	CcSEcCtD
Hydralazine—Malaise—Donepezil—Alzheimer's disease	0.00141	0.00411	CcSEcCtD
Hydralazine—Constipation—Galantamine—Alzheimer's disease	0.00141	0.0041	CcSEcCtD
Hydralazine—RYR2—SIDS Susceptibility Pathways—NGF—Alzheimer's disease	0.0014	0.0128	CbGpPWpGaD
Hydralazine—Feeling abnormal—Galantamine—Alzheimer's disease	0.00135	0.00395	CcSEcCtD
Hydralazine—Muscle spasms—Rivastigmine—Alzheimer's disease	0.00133	0.00389	CcSEcCtD
Hydralazine—Arthralgia—Donepezil—Alzheimer's disease	0.00133	0.00388	CcSEcCtD
Hydralazine—Myalgia—Donepezil—Alzheimer's disease	0.00133	0.00388	CcSEcCtD
Hydralazine—RYR2—SIDS Susceptibility Pathways—HTR2A—Alzheimer's disease	0.00133	0.0122	CbGpPWpGaD
Hydralazine—Tremor—Memantine—Alzheimer's disease	0.00133	0.00387	CcSEcCtD
Hydralazine—Anxiety—Donepezil—Alzheimer's disease	0.00132	0.00386	CcSEcCtD
Hydralazine—Ill-defined disorder—Memantine—Alzheimer's disease	0.00131	0.00384	CcSEcCtD
Hydralazine—Discomfort—Donepezil—Alzheimer's disease	0.00131	0.00383	CcSEcCtD
Hydralazine—Anaemia—Memantine—Alzheimer's disease	0.00131	0.00382	CcSEcCtD
Hydralazine—Agitation—Memantine—Alzheimer's disease	0.0013	0.0038	CcSEcCtD
Hydralazine—Body temperature increased—Galantamine—Alzheimer's disease	0.0013	0.00379	CcSEcCtD
Hydralazine—Tremor—Rivastigmine—Alzheimer's disease	0.0013	0.00379	CcSEcCtD
Hydralazine—Ill-defined disorder—Rivastigmine—Alzheimer's disease	0.00129	0.00375	CcSEcCtD
Hydralazine—RYR2—Calcium Regulation in the Cardiac Cell—CALM1—Alzheimer's disease	0.00129	0.0118	CbGpPWpGaD
Hydralazine—Anaemia—Rivastigmine—Alzheimer's disease	0.00128	0.00374	CcSEcCtD
Hydralazine—Malaise—Memantine—Alzheimer's disease	0.00128	0.00373	CcSEcCtD
Hydralazine—Agitation—Rivastigmine—Alzheimer's disease	0.00127	0.00372	CcSEcCtD
Hydralazine—Oedema—Donepezil—Alzheimer's disease	0.00127	0.00372	CcSEcCtD
Hydralazine—Leukopenia—Memantine—Alzheimer's disease	0.00127	0.0037	CcSEcCtD
Hydralazine—Palpitations—Memantine—Alzheimer's disease	0.00125	0.00365	CcSEcCtD
Hydralazine—Malaise—Rivastigmine—Alzheimer's disease	0.00125	0.00365	CcSEcCtD
Hydralazine—Thrombocytopenia—Donepezil—Alzheimer's disease	0.00125	0.00364	CcSEcCtD
Hydralazine—RYR2—Myometrial Relaxation and Contraction Pathways—CALM1—Alzheimer's disease	0.00125	0.0115	CbGpPWpGaD
Hydralazine—Palpitations—Rivastigmine—Alzheimer's disease	0.00122	0.00358	CcSEcCtD
Hydralazine—Anorexia—Donepezil—Alzheimer's disease	0.00121	0.00354	CcSEcCtD
Hydralazine—Hypersensitivity—Galantamine—Alzheimer's disease	0.00121	0.00353	CcSEcCtD
Hydralazine—Arthralgia—Memantine—Alzheimer's disease	0.00121	0.00352	CcSEcCtD
Hydralazine—Myalgia—Memantine—Alzheimer's disease	0.00121	0.00352	CcSEcCtD
Hydralazine—Anxiety—Memantine—Alzheimer's disease	0.0012	0.00351	CcSEcCtD
Hydralazine—Discomfort—Memantine—Alzheimer's disease	0.00119	0.00348	CcSEcCtD
Hydralazine—CYP3A4—Codeine and Morphine Metabolism—CYP2D6—Alzheimer's disease	0.00119	0.0109	CbGpPWpGaD
Hydralazine—Hypotension—Donepezil—Alzheimer's disease	0.00119	0.00347	CcSEcCtD
Hydralazine—Arthralgia—Rivastigmine—Alzheimer's disease	0.00118	0.00344	CcSEcCtD
Hydralazine—Myalgia—Rivastigmine—Alzheimer's disease	0.00118	0.00344	CcSEcCtD
Hydralazine—Anxiety—Rivastigmine—Alzheimer's disease	0.00118	0.00343	CcSEcCtD
Hydralazine—Discomfort—Rivastigmine—Alzheimer's disease	0.00117	0.0034	CcSEcCtD
Hydralazine—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.00116	0.00339	CcSEcCtD
Hydralazine—Oedema—Memantine—Alzheimer's disease	0.00116	0.00338	CcSEcCtD
Hydralazine—CYP3A4—nervous system—Alzheimer's disease	0.00116	0.00889	CbGeAlD
Hydralazine—Paraesthesia—Donepezil—Alzheimer's disease	0.00114	0.00334	CcSEcCtD
Hydralazine—Dyspnoea—Donepezil—Alzheimer's disease	0.00114	0.00331	CcSEcCtD
Hydralazine—Thrombocytopenia—Memantine—Alzheimer's disease	0.00113	0.0033	CcSEcCtD
Hydralazine—Oedema—Rivastigmine—Alzheimer's disease	0.00113	0.0033	CcSEcCtD
Hydralazine—Tachycardia—Memantine—Alzheimer's disease	0.00113	0.00329	CcSEcCtD
Hydralazine—Diarrhoea—Galantamine—Alzheimer's disease	0.00112	0.00328	CcSEcCtD
Hydralazine—Dyspepsia—Donepezil—Alzheimer's disease	0.00112	0.00327	CcSEcCtD
Hydralazine—CYP3A4—central nervous system—Alzheimer's disease	0.00111	0.00856	CbGeAlD
Hydralazine—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.00111	0.00323	CcSEcCtD
Hydralazine—Decreased appetite—Donepezil—Alzheimer's disease	0.00111	0.00323	CcSEcCtD
Hydralazine—Tachycardia—Rivastigmine—Alzheimer's disease	0.0011	0.00322	CcSEcCtD
Hydralazine—Anorexia—Memantine—Alzheimer's disease	0.0011	0.00322	CcSEcCtD
Hydralazine—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.0011	0.00321	CcSEcCtD
Hydralazine—Constipation—Donepezil—Alzheimer's disease	0.00109	0.00318	CcSEcCtD
Hydralazine—Dizziness—Galantamine—Alzheimer's disease	0.00109	0.00317	CcSEcCtD
Hydralazine—Hypotension—Memantine—Alzheimer's disease	0.00108	0.00315	CcSEcCtD
Hydralazine—Anorexia—Rivastigmine—Alzheimer's disease	0.00108	0.00315	CcSEcCtD
Hydralazine—RYR2—Myometrial Relaxation and Contraction Pathways—CREB1—Alzheimer's disease	0.00107	0.0098	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—CREB1—Alzheimer's disease	0.00106	0.00975	CbGpPWpGaD
Hydralazine—Hypotension—Rivastigmine—Alzheimer's disease	0.00106	0.00309	CcSEcCtD
Hydralazine—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.00105	0.00308	CcSEcCtD
Hydralazine—Feeling abnormal—Donepezil—Alzheimer's disease	0.00105	0.00306	CcSEcCtD
Hydralazine—Vomiting—Galantamine—Alzheimer's disease	0.00104	0.00305	CcSEcCtD
Hydralazine—Paraesthesia—Memantine—Alzheimer's disease	0.00104	0.00303	CcSEcCtD
Hydralazine—Rash—Galantamine—Alzheimer's disease	0.00104	0.00302	CcSEcCtD
Hydralazine—Dermatitis—Galantamine—Alzheimer's disease	0.00104	0.00302	CcSEcCtD
Hydralazine—Dyspnoea—Memantine—Alzheimer's disease	0.00103	0.00301	CcSEcCtD
Hydralazine—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.00103	0.00301	CcSEcCtD
Hydralazine—Headache—Galantamine—Alzheimer's disease	0.00103	0.003	CcSEcCtD
Hydralazine—Dyspepsia—Memantine—Alzheimer's disease	0.00102	0.00297	CcSEcCtD
Hydralazine—Paraesthesia—Rivastigmine—Alzheimer's disease	0.00102	0.00296	CcSEcCtD
Hydralazine—Urticaria—Donepezil—Alzheimer's disease	0.00101	0.00295	CcSEcCtD
Hydralazine—Dyspnoea—Rivastigmine—Alzheimer's disease	0.00101	0.00294	CcSEcCtD
Hydralazine—Body temperature increased—Donepezil—Alzheimer's disease	0.00101	0.00294	CcSEcCtD
Hydralazine—Decreased appetite—Memantine—Alzheimer's disease	0.00101	0.00293	CcSEcCtD
Hydralazine—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.000998	0.00291	CcSEcCtD
Hydralazine—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000996	0.00291	CcSEcCtD
Hydralazine—CYP3A4—Tryptophan metabolism—DHCR24—Alzheimer's disease	0.000993	0.00913	CbGpPWpGaD
Hydralazine—Constipation—Memantine—Alzheimer's disease	0.000989	0.00289	CcSEcCtD
Hydralazine—Decreased appetite—Rivastigmine—Alzheimer's disease	0.000983	0.00287	CcSEcCtD
Hydralazine—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.000977	0.00285	CcSEcCtD
Hydralazine—Nausea—Galantamine—Alzheimer's disease	0.000976	0.00285	CcSEcCtD
Hydralazine—Constipation—Rivastigmine—Alzheimer's disease	0.000967	0.00282	CcSEcCtD
Hydralazine—Feeling abnormal—Memantine—Alzheimer's disease	0.000953	0.00278	CcSEcCtD
Hydralazine—Hypersensitivity—Donepezil—Alzheimer's disease	0.000938	0.00274	CcSEcCtD
Hydralazine—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000932	0.00272	CcSEcCtD
Hydralazine—RYR2—Myometrial Relaxation and Contraction Pathways—NOS3—Alzheimer's disease	0.00093	0.00855	CbGpPWpGaD
Hydralazine—Urticaria—Memantine—Alzheimer's disease	0.000919	0.00268	CcSEcCtD
Hydralazine—RYR2—Transmembrane transport of small molecules—CP—Alzheimer's disease	0.000915	0.00841	CbGpPWpGaD
Hydralazine—Body temperature increased—Memantine—Alzheimer's disease	0.000914	0.00267	CcSEcCtD
Hydralazine—Pruritus—Donepezil—Alzheimer's disease	0.000901	0.00263	CcSEcCtD
Hydralazine—Urticaria—Rivastigmine—Alzheimer's disease	0.000899	0.00262	CcSEcCtD
Hydralazine—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000894	0.00261	CcSEcCtD
Hydralazine—Diarrhoea—Donepezil—Alzheimer's disease	0.000871	0.00254	CcSEcCtD
Hydralazine—CYP3A4—Constitutive Androstane Receptor Pathway—PPP2R4—Alzheimer's disease	0.000855	0.00787	CbGpPWpGaD
Hydralazine—Hypersensitivity—Memantine—Alzheimer's disease	0.000852	0.00249	CcSEcCtD
Hydralazine—Dizziness—Donepezil—Alzheimer's disease	0.000842	0.00246	CcSEcCtD
Hydralazine—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000833	0.00243	CcSEcCtD
Hydralazine—Pruritus—Memantine—Alzheimer's disease	0.000818	0.00239	CcSEcCtD
Hydralazine—Vomiting—Donepezil—Alzheimer's disease	0.00081	0.00236	CcSEcCtD
Hydralazine—Rash—Donepezil—Alzheimer's disease	0.000803	0.00234	CcSEcCtD
Hydralazine—Dermatitis—Donepezil—Alzheimer's disease	0.000802	0.00234	CcSEcCtD
Hydralazine—Pruritus—Rivastigmine—Alzheimer's disease	0.0008	0.00234	CcSEcCtD
Hydralazine—Headache—Donepezil—Alzheimer's disease	0.000798	0.00233	CcSEcCtD
Hydralazine—Diarrhoea—Memantine—Alzheimer's disease	0.000791	0.00231	CcSEcCtD
Hydralazine—RYR2—Myometrial Relaxation and Contraction Pathways—IL1B—Alzheimer's disease	0.000791	0.00728	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—IL1B—Alzheimer's disease	0.000787	0.00724	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—CASP3—Alzheimer's disease	0.000785	0.00722	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—TF—Alzheimer's disease	0.000778	0.00715	CbGpPWpGaD
Hydralazine—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000774	0.00226	CcSEcCtD
Hydralazine—Dizziness—Memantine—Alzheimer's disease	0.000765	0.00223	CcSEcCtD
Hydralazine—Nausea—Donepezil—Alzheimer's disease	0.000756	0.00221	CcSEcCtD
Hydralazine—Dizziness—Rivastigmine—Alzheimer's disease	0.000748	0.00218	CcSEcCtD
Hydralazine—Vomiting—Memantine—Alzheimer's disease	0.000735	0.00215	CcSEcCtD
Hydralazine—Rash—Memantine—Alzheimer's disease	0.000729	0.00213	CcSEcCtD
Hydralazine—Dermatitis—Memantine—Alzheimer's disease	0.000728	0.00213	CcSEcCtD
Hydralazine—Headache—Memantine—Alzheimer's disease	0.000724	0.00211	CcSEcCtD
Hydralazine—CYP3A4—Irinotecan Pathway—BCHE—Alzheimer's disease	0.000721	0.00663	CbGpPWpGaD
Hydralazine—Vomiting—Rivastigmine—Alzheimer's disease	0.000719	0.0021	CcSEcCtD
Hydralazine—Rash—Rivastigmine—Alzheimer's disease	0.000713	0.00208	CcSEcCtD
Hydralazine—Dermatitis—Rivastigmine—Alzheimer's disease	0.000713	0.00208	CcSEcCtD
Hydralazine—Headache—Rivastigmine—Alzheimer's disease	0.000709	0.00207	CcSEcCtD
Hydralazine—CYP3A4—Tryptophan metabolism—HSD17B10—Alzheimer's disease	0.000688	0.00633	CbGpPWpGaD
Hydralazine—Nausea—Memantine—Alzheimer's disease	0.000687	0.002	CcSEcCtD
Hydralazine—CYP3A4—Fatty Acid Omega Oxidation—CYP2D6—Alzheimer's disease	0.000684	0.00629	CbGpPWpGaD
Hydralazine—Nausea—Rivastigmine—Alzheimer's disease	0.000672	0.00196	CcSEcCtD
Hydralazine—RYR2—SIDS Susceptibility Pathways—VEGFA—Alzheimer's disease	0.000666	0.00613	CbGpPWpGaD
Hydralazine—CYP3A4—Xenobiotics—CYP2D6—Alzheimer's disease	0.000572	0.00526	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—TNF—Alzheimer's disease	0.000571	0.00525	CbGpPWpGaD
Hydralazine—CYP3A4—Tamoxifen metabolism—CYP2D6—Alzheimer's disease	0.00055	0.00506	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	0.000544	0.005	CbGpPWpGaD
Hydralazine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP46A1—Alzheimer's disease	0.000536	0.00493	CbGpPWpGaD
Hydralazine—CYP3A4—Oxidation by Cytochrome P450—CYP46A1—Alzheimer's disease	0.000529	0.00486	CbGpPWpGaD
Hydralazine—RYR2—Myometrial Relaxation and Contraction Pathways—IL6—Alzheimer's disease	0.000463	0.00426	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—IL6—Alzheimer's disease	0.000461	0.00424	CbGpPWpGaD
Hydralazine—CYP3A4—Farnesoid X Receptor  Pathway—PPARGC1A—Alzheimer's disease	0.000445	0.0041	CbGpPWpGaD
Hydralazine—CYP3A4—Phase 1 - Functionalization of compounds—CYP46A1—Alzheimer's disease	0.000434	0.00399	CbGpPWpGaD
Hydralazine—CYP3A4—Tryptophan metabolism—MAOB—Alzheimer's disease	0.000395	0.00364	CbGpPWpGaD
Hydralazine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—Alzheimer's disease	0.000324	0.00298	CbGpPWpGaD
Hydralazine—CYP3A4—Constitutive Androstane Receptor Pathway—PPARGC1A—Alzheimer's disease	0.000294	0.0027	CbGpPWpGaD
Hydralazine—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—Alzheimer's disease	0.000259	0.00238	CbGpPWpGaD
Hydralazine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—Alzheimer's disease	0.000238	0.00218	CbGpPWpGaD
Hydralazine—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—Alzheimer's disease	0.000234	0.00216	CbGpPWpGaD
Hydralazine—CYP3A4—Biological oxidations—CYP46A1—Alzheimer's disease	0.000231	0.00212	CbGpPWpGaD
Hydralazine—CYP3A4—Metapathway biotransformation—CYP46A1—Alzheimer's disease	0.000227	0.00209	CbGpPWpGaD
Hydralazine—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—Alzheimer's disease	0.000196	0.00181	CbGpPWpGaD
Hydralazine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—Alzheimer's disease	0.000193	0.00177	CbGpPWpGaD
Hydralazine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Alzheimer's disease	0.000186	0.00171	CbGpPWpGaD
Hydralazine—CYP3A4—Biological oxidations—MAOB—Alzheimer's disease	0.000138	0.00127	CbGpPWpGaD
Hydralazine—CYP3A4—Biological oxidations—PTGS1—Alzheimer's disease	0.000104	0.000959	CbGpPWpGaD
Hydralazine—CYP3A4—Biological oxidations—CYP2D6—Alzheimer's disease	0.000102	0.000941	CbGpPWpGaD
Hydralazine—CYP3A4—Metapathway biotransformation—CYP2D6—Alzheimer's disease	0.000101	0.000928	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—DHCR24—Alzheimer's disease	5.91e-05	0.000544	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—CA4—Alzheimer's disease	5.03e-05	0.000462	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—GAPDHS—Alzheimer's disease	4.73e-05	0.000435	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—ATP5A1—Alzheimer's disease	4.48e-05	0.000412	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—PLD3—Alzheimer's disease	4.27e-05	0.000393	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—HSD17B10—Alzheimer's disease	4.1e-05	0.000377	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—CYP46A1—Alzheimer's disease	3.94e-05	0.000363	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—ND1—Alzheimer's disease	3.81e-05	0.00035	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—TPI1—Alzheimer's disease	2.45e-05	0.000226	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—CHAT—Alzheimer's disease	2.45e-05	0.000226	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—MAOB—Alzheimer's disease	2.35e-05	0.000216	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	2.27e-05	0.000208	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—A2M—Alzheimer's disease	2.19e-05	0.000201	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—ACHE—Alzheimer's disease	1.9e-05	0.000175	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	1.88e-05	0.000173	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—ENO1—Alzheimer's disease	1.78e-05	0.000164	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	1.78e-05	0.000164	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	1.75e-05	0.000161	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—BCHE—Alzheimer's disease	1.66e-05	0.000152	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	1.56e-05	0.000144	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	1.52e-05	0.000139	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	1.31e-05	0.00012	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	1.3e-05	0.00012	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—LPL—Alzheimer's disease	1.19e-05	0.000109	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	1.07e-05	9.85e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—CALM1—Alzheimer's disease	1e-05	9.21e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—APOE—Alzheimer's disease	9.98e-06	9.17e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—CAV1—Alzheimer's disease	9.88e-06	9.09e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—PPARG—Alzheimer's disease	8.69e-06	7.99e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—INS—Alzheimer's disease	8.52e-06	7.84e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—NOS3—Alzheimer's disease	7.47e-06	6.87e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	6.84e-06	6.29e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—AKT1—Alzheimer's disease	3.44e-06	3.16e-05	CbGpPWpGaD
